Skip to main content

Rockwell Medical Value Stock - Dividend - Research Selection

Rockwell medical

ISIN: US7743741024 , WKN: 916118

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company\'s lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient\'s bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company\'s target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Rockwell Medical, Inc. (NASDAQ:RMTI): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Rockwell Medical, Inc.'s ( NASDAQ:RMTI ) business as it appears the...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, and welcome to Rockwell Medical’s Third Quarter 2023 Results Conference Call and Webcast. Please note this event is being recorded. At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate […]

Rockwell Medical’s Steady Performance and Growth Potential Warrants a Buy Rating: An Analytical Overview

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Q3 2023 Rockwell Medical Inc Earnings Call

Q3 2023 Rockwell Medical Inc Earnings Call

Rockwell Med’s Strong Q3 Results and Strategic Market Maneuvers Drive Positive Analyst Recommendation

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 41.67% and 0.43%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Announces Third Quarter 2023 Results

WIXOM, Mich., November 14, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months ended September 30, 2023.

Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:NASDAQ:RMTI) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ETCompany ParticipantsHeather Hunter - SVP &...

Rockwell Medical : Q3 Earnings Snapshot

WIXOM, Mich. — WIXOM, Mich. — Rockwell Medical Inc. on Tuesday reported a loss of $1.9 million in its third quarter. On a per-share basis, the Wixom, Michigan-based company said it had a...

Rockwell Medical: Q3 Earnings Snapshot

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.